AWA
CLB icon

Arete Wealth Advisors’s Core Laboratories CLB Stock Holding History

Arete Wealth Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26,939
Closed -$3.11M – 234
2017
Q1 		$3.11M Buy
26,939
+101
+0.4% +$11.7K 1.36% 19
2016
Q4 		$3.22M Buy
+26,838
New +$2.97M 1.49% 13

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arete Wealth Advisors's CLB Position: Q2 2017 in Review

Arete Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 26,939 shares — an estimated $3.11M sold.

Arete Wealth Advisors first reported a position in CLB in Q4 2016 and held it in 2 quarters. The position peaked at $3.22M in Q4 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Arete Wealth Advisors reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Arete Wealth Advisors sold 26,939 Core Laboratories shares in Q2 2017, an estimated $3.11M.
  • Arete Wealth Advisors first reported a position in Core Laboratories in Q4 2016 and held it in 2 quarters.
  • Arete Wealth Advisors's Core Laboratories position peaked at $3.22M in Q4 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Arete Wealth Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.